endogenous glp-1 GLP1 Receptor Agonists—Effects beyond Obesity and Diabetes The protective role of GLP-1
Description
Mindful and circadian-aligned eating
doi: 10.1002/jgh3.12780
Similarly to type 1 diabetes, it has no cure, and treatment is aimed at relieving the most uncomfortable of symptoms
They essentially amplify the bodys own satiety cues, Hardaway explained
No high-quality clinical trials have specifically investigated microdosing as a therapeutic strategy
This result suggested that the long-acting form, unlike the short-acting forms (lixisenatide and exenatide), of exendin-4-based GLP-1RAs improved cardiovascular outcomes
